1. Pfohler C, Muller CS, Hasselmann DO, Tilgen W. Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report. J Med Case Rep. 2008; 2:283.
2. Hong JH, Lee JH, Shin JH, Kim DP, Ko BS, Kim BJ, et al. Maintenance of insulin therapy by desensitization in insulin allergy patient. Korean Diabetes J. 2008; 32:529–531.
Article
3. Kim MH, Lim KH, Park HK, Kim BK, Kang MK, Kwon JW, et al. A case of change of insulin-specific antibodies following desensitization in insulin hypersensitivity patients. Korean J Asthma Allergy Clin Immunol. 2010; 30:63–67.
4. Oh TK, Jung JI, Hahn Z, Kim MK. A case of human insulin allergy induced by rapid acting human recombinant insulin, humulin-R. Korean J Asthma Allergy Clin Immunol. 2006; 26:155–158.
5. Castera V, Dutour-Meyer A, Koeppel M, Petitjean C, Darmon P. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion. Diabetes Metab. 2005; 31:391–400.
Article
6. Sohn I, Kim YY, Kang SY. Two cases of insulin allergy. J Asthma Allergy Clin Immunol. 1981; 1:126–130.
7. Kim SY, Kim YY, Lee HK, Kang SY. A case of insulin allergy treated by desensitization. J Asthma Allergy Clin Immunol. 1982; 2:35–40.
8. Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol. 2002; 82:114–117.
Article
9. Adachi A, Fukunaga A, Horikawa T. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin. Int J Dermatol. 2004; 43:597–599.
Article
10. Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev. 2007; 23:348–355.
Article
11. Asai M, Yoshida M, Miura Y. Immunologic tolerance to intravenously injected insulin. N Engl J Med. 2006; 354:307–309.
Article
12. Bodtger U, Wittrup M. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med. 2005; 22:102–106.
Article
13. Ghazavi MK, Johnston GA. Insulin allergy. Clin Dermatol. 2011; 29:300–305.
Article
14. Ben Ammar I, Ksouri H, Trabelsi N, Mellouli F, Ben Mami F, Dakhli S, et al. Generalized allergy due to zinc in insulin treated with zinc-free insulin. Acta Diabetol. 2012; 49:239–241.
Article
15. Wheeler BJ, Taylor BJ. Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report. J Med Case Rep. 2012; 6:263.
Article
16. Clerx V, Van Den, Kochuyt A, Goossens A. Drug intolerance reaction to insulin therapy caused by metacresol. Contact Dermatitis. 2003; 48:162–163.
Article